This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bellaton, E Articles by Desjardins, L Search for Related Content PubMed PubMed Citation Articles by Bellaton, E Articles by Desjardins, L Topic Collections Relevant Article

Neoadjuvant chemotherapy for extensive unilateral retinoblastoma

¹ Institut Curie, Paris, France
² CHU Toulouse, France
³ CHU Reims, France
⁴ CHU Nancy, France
⁵ CHU Necker Enfants Malades, Paris, France

Correspondence to:
Correspondence to:
François Doz, Département d’Oncologie Pédiatrique, Institut Curie, 26 rue d’Ulm, 75231 Paris Cedex 05, France;
Francois.Doz{at}curie.net

Aim: The role of neoadjuvant chemotherapy was studied when first line enucleation cannot be safely performed in unilateral extensive retinoblastoma (major buphthalmia or radiologically detectable optic nerve involvement).

Methods: Six patients, referred for unilateral retinoblastoma, presented with major buphthalmia (two) or optic nerve invasion (four): they were treated by neoadjuvant chemotherapy using etoposide and carboplatin.

Results: Good tumour response was observed in the two patients with buphthalmia and in three of four cases with optic nerve involvement. Meningeal progressive disease was observed in the last patient. The five patients without disease progression were then operated on: anterior enucleation in the patients with buphthalmia and enucleation via a double neurosurgical and ophthalmological approach with prechiasmatic optic nerve section in the other three cases. Postoperative chemotherapy was performed in these five patients. Local radiotherapy to the chiasmatic region and posterior part of the optic canal was necessary in only one patient. The non-operated patient died with disease progression 6 months after the diagnosis. The other five patients are alive with a follow up of 12, 15, 21, 36, and 40 months after stopping treatment.

Conclusion: Neoadjuvant chemotherapy can be useful in extensive unilateral retinoblastoma with buphthalmia and/or radiological optic nerve invasion at diagnosis.

Keywords: retinoblastoma; chemotherapy; enucleation

Relevant Article

BJO at a glance

Creig Hoyt
Br. J. Ophthalmol. 2003 87: 253. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				P de Graaf, A C Moll, S M Imhof, P van der Valk, and J A Castelijns Retinoblastoma and optic nerve enhancement on MRI: not always extraocular tumour extension Br. J. Ophthalmol., June 1, 2006; 90(6): 800 - 801. [Full Text] [PDF]